ERVW-1 and infection: In the case of the HBV/HCV, it is tempting to speculate that activation of the ERAD pathway would limit the amount of surface proteins available for nucleocapsid envelopment, on one hand, and avoid extensive damage of the ER due to viral protein accumulation, on the other hand, thus enabling the evolution of infection toward chronicity.